Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

FDA Approval

Terazosin

CompanyState of Florida DOH Central Pharmacy (DUNS: 829348114)

Effective Date

January 19, 2015

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Active Ingredients

Terazosin(1 mg in 1 1)

Manufacturing Establishments (1)

State of Florida DOH Central Pharmacy

Labeler

State of Florida DOH Central Pharmacy

DUNS Number

829348114

Products (1)

Terazosin

NDC Product Code

53808-1056

Application Number

ANDA075317

Marketing Category

ANDA (C73584)

Route of Administration

ORAL

Effective Date

January 19, 2015

Ingredients

FERROSOFERRIC OXIDEInactive

Code: XM0M87F357Class: IACT

GELATINInactive

Code: 2G86QN327LClass: IACT

LACTOSE MONOHYDRATEInactive

Code: EWQ57Q8I5XClass: IACT

TerazosinActive

Code: D32S14F082Class: ACTIMQuantity: 1 mg in 1 1

MAGNESIUM STEARATEInactive

Code: 70097M6I30Class: IACT

SODIUM LAURYL SULFATEInactive

Code: 368GB5141JClass: IACT

TITANIUM DIOXIDEInactive

Code: 15FIX9V2JPClass: IACT

STARCH, CORNInactive

Code: O8232NY3SJClass: IACT

COLLOIDAL SILICON DIOXIDEInactive

Code: ETJ7Z6XBU4Class: IACT

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy